The effectiveness of nicotine-patch therapy for smoking cessation in patients with schizophrenia.
D000279:Administration, Cutaneous; D000328:Adult; D002248:Carbon Monoxide / Q000097:blood; D005260:Female; D005731:Ganglionic Stimulants / Q000008:administration & dosage*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009538:Nicotine / Q000008:administration & dosage*; D010349:Patient Compliance; D015995:Prevalence; D012559:Schizophrenia / Q000150:complications*; D012565:Schizophrenic Psychology; D012907:Smoking / Q000097:blood / Q000453:epidemiology / Q000523:psychology; D016540:Smoking Cessation / Q000379:methods* / Q000523:psychology; D000074606:Smoking Prevention; D011795:Surveys and Questionnaires; D014029:Tobacco Use Disorder / Q000097:blood / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control* / Q000523:psychology; D016896:Treatment Outcome
D005731:Ganglionic Stimulants; D009538:Nicotine; D002248:Carbon Monoxide